José A. Roca

1.6k total citations
29 papers, 1.2k citations indexed

About

José A. Roca is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, José A. Roca has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Ophthalmology, 17 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in José A. Roca's work include Retinal Diseases and Treatments (21 papers), Retinal and Optic Conditions (13 papers) and Ocular Diseases and Behçet’s Syndrome (12 papers). José A. Roca is often cited by papers focused on Retinal Diseases and Treatments (21 papers), Retinal and Optic Conditions (13 papers) and Ocular Diseases and Behçet’s Syndrome (12 papers). José A. Roca collaborates with scholars based in Peru, Brazil and Costa Rica. José A. Roca's co-authors include Lihteh Wu, J. Fernando Arévalo, María H. Berrocal, Maurício Maia, Francisco J. Rodríguez, Michel Eid Farah, Hugo Quiroz–Mercado, María Ana Martinez-Castellanos, Erick Hernández-Bogantes and Virgilio Morales-Cantón and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Joint Surgery and Ophthalmology.

In The Last Decade

José A. Roca

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José A. Roca Peru 17 1.1k 625 111 75 52 29 1.2k
Carlo Sborgia Italy 17 902 0.8× 701 1.1× 63 0.6× 97 1.3× 34 0.7× 52 1.1k
Dan Bourla Israel 14 381 0.4× 383 0.6× 75 0.7× 122 1.6× 33 0.6× 29 626
Claudio Furino Italy 20 1.1k 1.1× 735 1.2× 99 0.9× 77 1.0× 20 0.4× 69 1.2k
L. A. Yannuzzi United States 15 864 0.8× 518 0.8× 120 1.1× 80 1.1× 40 0.8× 30 972
Frank Hiu Ping Lai Hong Kong 12 539 0.5× 315 0.5× 77 0.7× 77 1.0× 51 1.0× 20 620
Alexander F. Scheuerle Germany 18 862 0.8× 661 1.1× 73 0.7× 111 1.5× 72 1.4× 55 1.0k
Fatih Ulaş Türkiye 12 351 0.3× 210 0.3× 55 0.5× 43 0.6× 17 0.3× 47 431
Daniel Su United States 12 475 0.4× 401 0.6× 56 0.5× 50 0.7× 73 1.4× 27 597
Ho Seok Chung South Korea 13 571 0.5× 462 0.7× 81 0.7× 39 0.5× 17 0.3× 42 733
Leandro Cabral Zacharias Brazil 13 424 0.4× 307 0.5× 82 0.7× 55 0.7× 36 0.7× 72 538

Countries citing papers authored by José A. Roca

Since Specialization
Citations

This map shows the geographic impact of José A. Roca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Roca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Roca more than expected).

Fields of papers citing papers by José A. Roca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Roca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Roca. The network helps show where José A. Roca may publish in the future.

Co-authorship network of co-authors of José A. Roca

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Roca. A scholar is included among the top collaborators of José A. Roca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Roca. José A. Roca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chhablani, Jay, Joshua Ong, Xinyuan Zhang, et al.. (2022). Subthreshold laser therapy guidelines for retinal diseases. Eye. 36(12). 2234–2235. 16 indexed citations
2.
Roca, José A., et al.. (2021). Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(10). 2913–2917. 22 indexed citations
3.
Wu, Lihteh, María H. Berrocal, Roberto Gallego‐Pinazo, et al.. (2021). Five-year outcomes after intravitreal bevacizumab of treatment-naive eyes with macular edema secondary to CRVO in routine clinical practice: Results of the Pan-American Collaborative Retina Study (PACORES) group. International Ophthalmology. 42(3). 951–958. 5 indexed citations
4.
Roca, José A., Maurício Maia, Natasha Ferreira Santos da Cruz, et al.. (2020). Non-contact wide-angled visualization with chandelier-assisted scleral buckling for primary uncomplicated rhegmatogenous retinal detachment. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(9). 1857–1861. 9 indexed citations
5.
Schlottmann, Patricio G., Arturo Alezzandrini, Joaquín Bafalluy, et al.. (2014). Defining Best Practice Standards for the Diagnosis and Management of Diabetic Retinopathy and Diabetic Macular Edema in Latin America. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Wu, Lihteh, María H. Berrocal, Francisco J. Rodríguez, et al.. (2014). INTRAOCULAR PRESSURE ELEVATION AFTER UNCOMPLICATED PARS PLANA VITRECTOMY. Retina. 34(10). 1985–1989. 49 indexed citations
7.
Wu, Lihteh, J. Fernando Arévalo, Erick Hernández-Bogantes, et al.. (2012). Intravitreal Tumor Necrosis Factor-Alpha Inhibitors for Neovascular Age-Related Macular Degeneration Suboptimally Responsive to Antivascular Endothelial Growth Factor Agents: A Pilot Study from the Pan American Collaborative Retina Study Group. Journal of Ocular Pharmacology and Therapeutics. 29(3). 366–371. 28 indexed citations
8.
Wu, Lihteh, J. Fernando Arévalo, Erick Hernández-Bogantes, & José A. Roca. (2012). Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group. International Ophthalmology. 32(3). 235–243. 37 indexed citations
9.
Wu, Lihteh, María H. Berrocal, J. Fernando Arévalo, et al.. (2011). ENDOPHTHALMITIS AFTER PARS PLANA VITRECTOMY. Retina. 31(4). 673–678. 59 indexed citations
10.
Wu, Lihteh, J. Fernando Arévalo, María H. Berrocal, et al.. (2010). COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. Retina. 30(7). 1002–1011. 30 indexed citations
11.
Wu, Lihteh, et al.. (2010). INTRAVITREAL TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA. Retina. 31(2). 298–303. 75 indexed citations
12.
Wu, Lihteh, María H. Berrocal, Maurício Maia, et al.. (2009). Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Macular Edema Secondary to Retinal Vein Occlusions: Results of the Pan American Collaborative Retina Study Group (PACORES) at 24 Months. Investigative Ophthalmology & Visual Science. 50(13). 5390–5390. 1 indexed citations
13.
Arévalo, J. Fernando, Maurício Maia, José A. Roca, et al.. (2009). Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema. Ophthalmology. 116(8). 1481–1487.e1. 76 indexed citations
14.
Wu, Lihteh, María H. Berrocal, Maurício Maia, et al.. (2009). COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONS. Retina. 29(10). 1396–1403. 41 indexed citations
15.
Arévalo, J. Fernando, Lihteh Wu, Francisco J. Rodríguez, et al.. (2008). RADIAL OPTIC NEUROTOMY FOR CENTRAL RETINAL VEIN OCCLUSION. Retina. 28(8). 1044–1052. 36 indexed citations
16.
Roca, José A., Lihteh Wu, Maurício Maia, et al.. (2007). Intravitreal Bevacizumab (Avastin(R)) for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results of the Pan-American Collaborative Retina Study Group (PACORES). Investigative Ophthalmology & Visual Science. 48(13). 91–91. 5 indexed citations
17.
Fromow-Guerra, Jans, Hugo Quiroz–Mercado, J. García Sánchez, et al.. (2007). Primary Intravitreal Bevacizumab (Avastin) for the Treatment of Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD): Results of the Pan-American Collaborative Retina Study Group (PACORES) at 6-Months Follow-Up. Investigative Ophthalmology & Visual Science. 48(13). 4569–4569. 2 indexed citations
18.
Wu, Lihteh, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado, et al.. (2007). Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefe s Archive for Clinical and Experimental Ophthalmology. 246(1). 81–87. 374 indexed citations
19.
Quiroz–Mercado, Hugo, José A. Roca, Fernando Arévalo, et al.. (2006). Safety of an Intravitreal Injection of Bevacizumab (Avastin): Results of a Multicenter Trial. Investigative Ophthalmology & Visual Science. 47(13). 5226–5226. 1 indexed citations
20.
Yoshizumi, Marc O., et al.. (1996). Ocular Iontophoretic Supplementation of Intravenous Foscarnet Therapy. American Journal of Ophthalmology. 122(1). 86–90. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026